The Effect of Platelet Rich Plasma on Non-scarring Alopecia

Completed · Not applicable

Conditions studied: Androgenetic Alopecia, Alopecia

In brief

The purpose of this study is to evaluate the clinical efficacy of platelet rich plasma (PRP) injections for non-scaring alopecia in women. A randomized, placebo-controlled clinical trial will be performed where patients with non-scarring alopecia will either receive injections of their own PRP or injections of normal saline (placebo). Patients in the treatment group (Group A) will have a small amount of their own blood drawn and have their PRP injected into their scalp four times. The injections will be given at weeks zero, four, eight, and twenty four. The placebo group (Group B) will be given the same schedule but will receive sham injections only and will not have any blood drawn. Both groups will have clinical data collected at all visits, including a screening visit before enrollment and a final assessment visit at week 40, for a total of 6 study visits per patient. Data collection will include representative photographs of the scalp and measurements of hair thickness. The results from the two groups will then be compared. In summary, all study participants will have a screening visit before enrollment, four study visits for sub-dermal scalp injections, and one final assessment visit at week 40.

Key facts

Study ID

NCT03689452

Run by

Icahn School of Medicine at Mount Sinai

People needed

30

Starts

2018-10-01

Expected to finish

2019-06-03

Last updated by the study team

2020-10-30

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Must understand and voluntarily sign an informed consent form
• Must be female between the ages of 18 and 65 years at the time of consent
• Must be able to adhere to the study visit schedule and other protocol requirements
• Documented platelet count above 150,000 platelets per microliter within 6 months prior to enrollment

You may not qualify if…

• Previous or current use in the last 1 year of finasteride, minoxidil topical or oral, or spironolactone
• A diagnosis of non-androgenic alopecia (i.e: another diagnosis for the alopecia )
• No Baseline ferritin, thyroid-stimulating hormone, platelet count, and a negative urine pregnancy test in any pre-menopausal female in past 12 months.
• Active skin disease (Psoriasis or severe seborrheic dermatitis) of the scalp
• Scalp infection
• Severe active blood infection
• Cuts or abrasions on the scalp
• History of surgical hair restoration
• Current or recent malignancy
• History of systemic chemotherapy or radiation
• History of thyroid dysfunction
• History of autoimmune disorder (specifically Graves disease, hashimoto thyroiditis, or systemic lupus erythematosus)
• Tendency to develop keloids
• Nonsteroidal anti-inflammatory or Vitamin E discontinued in the last 7-14 days
• Platelet dysfunction syndrome
• Thrombocytopenia less than 150,000
• Diagnosis of hypofibrinogenemia
• Anticipated pregnancy or trying to become pregnant in the next 2 years

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.